Rocket One Inc. Marketable Securities, Gain (Loss)
Rocket One Inc. (RKTO) reported Marketable Securities, Gain (Loss) of -$18.80 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesGainLoss · last filed 2023-11-13
- Rocket One Inc. marketable securities, gain (loss) for the quarter ending 2023-03-31 was -$18.80K, a 185.67% decline year-over-year.
- Rocket One Inc. marketable securities, gain (loss) for the quarter ending 2022-12-31 was -$254.85K.
- Rocket One Inc. marketable securities, gain (loss) for the quarter ending 2022-09-30 was $26.57K.
- Rocket One Inc. marketable securities, gain (loss) for the quarter ending 2022-06-30 was -$158.64K.
- Rocket One Inc. marketable securities, gain (loss) for fiscal 2022 was -$386.91K.
- Rocket One Inc. marketable securities, gain (loss) for fiscal 2021 was -$152.68K.
| Period end | Marketable Securities, Gain (Loss) 3 month | Marketable Securities, Gain (Loss) 3 month as first filed | Marketable Securities, Gain (Loss) 6 month | Marketable Securities, Gain (Loss) 6 month as first filed | Marketable Securities, Gain (Loss) 9 month | Marketable Securities, Gain (Loss) 9 month as first filed | Marketable Securities, Gain (Loss) 12 month |
|---|---|---|---|---|---|---|---|
| 2023-03-31 | -$18.80K 10-Q · filed 2023-05-15 | -$273.65K derived: sum of 2 quarters · filed 2023-05-15 | -$247.08K derived: sum of 3 quarters · filed 2023-11-13 | -$405.71K derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-12-31 | -$254.85K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$228.27K derived: sum of 2 quarters · filed 2023-11-13 | -$386.91K derived: sum of 3 quarters · filed 2023-11-13 | -$386.91K 10-K · filed 2023-03-31 | |||
| 2022-09-30 | $26.57K 10-Q · filed 2023-11-13 | $40.77K 10-Q · filed 2022-11-10 | -$132.06K derived: sum of 2 quarters · filed 2023-11-13 | -$132.06K 10-Q · filed 2023-11-13 | -$266.91K 10-Q · filed 2022-11-10 | -$211.14K derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | -$158.64K 10-Q · filed 2023-08-11 | -$355.18K 10-Q · filed 2022-08-12 | -$158.63K 10-Q · filed 2023-08-11 | -$307.68K 10-Q · filed 2022-08-12 | -$237.71K derived: sum of 3 quarters · filed 2023-08-11 | -$251.43K derived: sum of 4 quarters · filed 2023-08-11 | |
| 2022-03-31 | $21.95K 10-Q · filed 2023-05-15 | $47.50K 10-Q · filed 2022-05-12 | -$79.08K derived: sum of 2 quarters · filed 2023-05-15 | -$92.79K derived: sum of 3 quarters · filed 2023-05-15 | -$150.14K derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | -$101.02K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$114.74K derived: sum of 2 quarters · filed 2023-03-31 | -$172.09K derived: sum of 3 quarters · filed 2023-03-31 | -$152.68K 10-K · filed 2023-03-31 | |||
| 2021-09-30 | -$13.72K 10-Q · filed 2022-11-10 | -$71.07K derived: sum of 2 quarters · filed 2022-11-10 | -$51.66K 10-Q · filed 2022-11-10 | ||||
| 2021-06-30 | -$57.35K 10-Q · filed 2022-08-12 | -$37.94K 10-Q · filed 2022-08-12 | |||||
| 2021-03-31 | $19.41K 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |